# Diabetes Research Center (DRC)

> **NIH NIH P30** · UNIVERSITY OF CALIFORNIA, SAN DIEGO · 2021 · $78,709

## Abstract

The overall mission of the UCSD/UCLA DRC centers on supporting research in the prevention and treatment
of diabetes and its complications to ultimately improve the lives of patients. For the past 17 years, our DRC has
been unique in linking together the diabetes/metabolism research activities of two major universities within the
UC system and their affiliated institutions in Southern California. This effort has fostered new collaborations
and interactions between outstanding scientists within and across these institutions. Our research base is
comprised of the following focus areas: Nuclear Receptors, Cell Signaling, Metabolism, Diabetes
Complications, and Islet/Beta Cell Biology. Each of these areas has outstanding leaders who facilitate
interactions and sharing of resources. The DRC has played an important role in promoting the careers of
young scientists as they move on to the status of independent investigators by awarding pilot and feasibility
grants. As an acknowledgement of our success in this effort, UCSD and UCLA have agreed to provide over
$100,000/year in additional unrestricted funds to augment our P&F program. The DRC will continue to advance
scientific and intellectual interactions by organizing and facilitating meetings, lectures, and mentoring efforts
that are part of our Enrichment Program. We will further accelerate diabetes research at the DRC Institutions
by providing state-of-the-art services through five cutting edge cores: A) The Transgenic and Knockout Mouse
Core, B) Metabolic and Molecular Physiology Core, C) Epigenetics and Genomics Core, D) Human Genetics
Core, and E) Targeted Pathway Analysis Core. All of our research cores have been updated with new services
and latest technologies in the upcoming project period to reflect the needs of our faculty, and the many
advances in this field as they relate to diabetes and metabolism research. Our efforts to support the cores and
facilitate collaboration have been successful, as can be judged by the numerous collaborative publications in
high impact journals and the substantial peer review grant support our faculty have accrued. The current
competitive renewal application includes many new scientific and technological advancements, including the
incorporation of novel genomic, proteomic, and metabolomics services that are now available to our members
in a streamlined and seamless fashion. Our future plans include the continued seamless integration of
research at all participating institutions to enhance technology and research capability within the DRC, to
promote the careers of promising young investigators through our successful P&F Program, and to accelerate
translational research activity and collaborations through interactions with the CTSA programs at both
institutions.

## Key facts

- **NIH application ID:** 10440063
- **Project number:** 3P30DK063491-19S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN DIEGO
- **Principal Investigator:** ALAN R. SALTIEL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $78,709
- **Award type:** 3
- **Project period:** 2002-12-01 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10440063

## Citation

> US National Institutes of Health, RePORTER application 10440063, Diabetes Research Center (DRC) (3P30DK063491-19S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10440063. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*